Ramamoorthy S, Cidlowski JA, Corticosteroids. Mechanisms of action in health and disease. Rheum Dis Clin North Am. 2016;42:15–31, vii. https://doi.org/10.1016/j.rdc.2015.08.002

Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2011;301:E11–24. https://doi.org/10.1152/ajpendo.00100.2011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchi D, van Eeden FJM. Homeostatic regulation of glucocorticoid receptor activity by hypoxia-inducible factor 1: from physiology to clinic. Cells. 2021;10:3441. https://doi.org/10.3390/cells10123441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chourpiliadis C, Aeddula NR, Physiology. Glucocorticoids. StatPearls. Treasure Island. (FL): StatPearls Publishing; 2023.

Google Scholar 

Hodgens A, Sharman T. In: StatPearls, editor. Corticosteroids. Treasure Island (FL): StatPearls Publishing; 2023.

Google Scholar 

Yasir M, Goyal A, Sonthalia S. In: StatPearls, editor. Corticosteroid adverse effects. Treasure Island (FL): StatPearls Publishing; 2023.

Google Scholar 

Gupta M, Gokarakonda SB, Regina AC. Withdrawal syndromes. StatPearls. Treasure Island. (FL): StatPearls Publishing; 2023.

Google Scholar 

He X, Findling JW, Auchus RJ. Glucocorticoid withdrawal syndrome following treatment of endogenous Cushing syndrome. Pituitary. 2022;25:393–403. https://doi.org/10.1007/s11102-022-01218-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Theiler-Schwetz V, Prete A. Glucocorticoid withdrawal syndrome: what to expect and how to manage. Curr Opin Endocrinol Diabetes Obes. 2023;30:167–74. https://doi.org/10.1097/MED.0000000000000804.

Article  PubMed  Google Scholar 

Alves C, Robazzi TC, Mendonça M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr (Rio J). 2008;84:192–202. https://doi.org/10.2223/JPED.1773.

Article  PubMed  Google Scholar 

Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS, et al. A systematic review of topical corticosteroid withdrawal (steroid addiction) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72:541–e92. https://doi.org/10.1016/j.jaad.2014.11.024.

Article  CAS  PubMed  Google Scholar 

Mohta A. Topical steroid withdrawal (Red skin Syndrome). In: Sathe NC, editor. StatPearls. Treasure Island (FL). StatPearls Publishing; 2024.

Jose J, Al Rubaie MH, Al Ramimmy H, Varughese SS, Pharmacovigilance. Basic concepts and an overview of the system in Oman. Sultan Qaboos Univ Med J. 2021;21:e161–3. https://doi.org/10.18295/squmj.2021.21.02.001.

Article  PubMed  PubMed Central  Google Scholar 

Hamid AAA, Rahim R, Teo SP. Pharmacovigilance and its importance for primary health care professionals. Korean J Fam Med. 2022;43:290–5. https://doi.org/10.4082/kjfm.21.0193.

Article  PubMed  PubMed Central  Google Scholar 

Dutta S, Kaur R, Charan J, Bhardwaj P, Ambwani SR, Babu S, et al. Analysis of neurological adverse events reported in vigibase from COVID-19 vaccines. Cureus. 2022;14:e21376. https://doi.org/10.7759/cureus.21376.

Article  PubMed  PubMed Central  Google Scholar 

VigiBase UMCWHO. Uppsala Monitoring Centre. https://who-umc.org/vigibase/. Accessed 10 Aug 2024.

Shankar PR, VigiAccess. Promoting public access to vigibase. Indian J Pharmacol. 2016;48:606–7. https://doi.org/10.4103/0253-7613.190766.

Article  PubMed  PubMed Central  Google Scholar 

Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72:905–8. https://doi.org/10.1111/j.1365-2125.2011.04037.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, et al. The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): explanation and elaboration. Drug Saf. 2024;47:585–99. https://doi.org/10.1007/s40264-024-01423-7.

Article  PubMed  PubMed Central  Google Scholar 

Faillie JL. Case-non-case studies: principle, methods, bias and interpretation. Therapie. 2019;74:225–32. https://doi.org/10.1016/j.therap.2019.01.006.

Article  PubMed  Google Scholar 

Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist. 2013;3:92–7. https://doi.org/10.1177/1941874412458678.

Article  PubMed  PubMed Central  Google Scholar 

Medicine for human use. European Medicines Agency. https://www.ema.europa.eu/en/medicines. Accessed 15 Oct 2024.

De Santis M, Saad F. Practical guidance on the role of corticosteroids in the treatment of metastatic castration-resistant prostate cancer. Urology. 2016;96:156–64. https://doi.org/10.1016/j.urology.2016.02.010.

Article  PubMed  Google Scholar 

Ndibe C, Wang CG, Sonpavde G. Corticosteroids in the management of prostate cancer: a critical review. Curr Treat Options Oncol. 2015;16:6. https://doi.org/10.1007/s11864-014-0320-6.

Article  PubMed  Google Scholar 

Wallace KL, Landsteiner A, Bunner SH, Engel-Nitz NM, Luckenbaugh AN. Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the united States. Cancer Causes Control. 2021;32:1365–74. https://doi.org/10.1007/s10552-021-01484-4.

Article  PubMed  Google Scholar 

Ocejo A, Correa R. In: StatPearls, editor. Methylprednisolone. Treasure Island (FL): StatPearls Publishing; 2024.

Google Scholar 

Drugs@FDA. Oct: FDA-Approved Drugs. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm. Accessed 12 2024.

Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients. Ther Adv Endocrinol Metab. 2019;10:2042018819848218. https://doi.org/10.1177/2042018819848218.

Article  PubMed  PubMed Central  Google Scholar 

Puckett Y, Gabbar A, Bokhari AA. In: StatPearls, editor. Prednisone. Treasure Island (FL): StatPearls Publishing; 2023.

Google Scholar 

Bjornsdottir HH, Einarsson ÓB, Gröndal G, Gudbjornsson B. Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users. SAGE Open Med. 2024;12:20503121241235056. https://doi.org/10.1177/20503121241235056.

Article  PubMed  PubMed Central  Google Scholar 

Martinez GJ, Appleton M, Kipp ZA, Loria AS, Min B, Hinds TD Jr. Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries. Physiol Rev. 2024;104:473–532. https://doi.org/10.1152/physrev.00021.2023.

Article  CAS  PubMed  Google Scholar 

Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L, et al. Why glucocorticoid withdrawal May sometimes be as dangerous as the treatment itself. Eur J Intern Med. 2013;24:714–20. https://doi.org/10.1016/j.ejim.2013.05.014.

Article  CAS  PubMed  Google Scholar 

Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, et al. European society of endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol. 2024;190:G25–51. https://doi.org/10.1093/ejendo/lvae029.

Article  PubMed  Google Scholar 

Elshimy G, Chippa V, Kaur J, Jeong JM. In: StatPearls, editor. Adrenal crisis. Treasure Island (FL): StatPearls Publishing; 2023.

Google Scholar 

Lee SC, Baranowski ES, Sakremath R, Saraff V, Mohamed Z. Hypoglycaemia in adrenal insufficiency. Front Endocrinol (Lausanne). 2023;14:1198519. https://doi.org/10.3389/fendo.2023.1198519.

Article  PubMed  Google Scholar 

Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls. Treasure Island. (FL): StatPearls Publishing; 2024.

Google Scholar 

Shah VP, Peck CC, Skelly JP. `Vasoconstriction’—skin blanching—assay for glucocorticoids—a critique. Arch Dermatol. 1989;125:1558–61. https://doi.org/10.1001/archderm.1989.01670230100019.

Article  CAS  PubMed  Google Scholar 

Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clin Cosmet Investig Dermatol. 2020;13:1041–50.